John A. Lewicki
Chief Scientific Officer · Mereo BioPharma Group plc
Individual
- 2026
- Feb 2, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John A. Lewicki's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John A. Lewicki?
John A. Lewicki is a corporate insider, tracked as Chief Scientific Officer of Mereo BioPharma Group plc (MREO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John A. Lewicki last file a Form 4?
The only primary Form 4 on record is dated 2 February 2026.